|
Status |
Public on Sep 05, 2017 |
Title |
Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment |
Organisms |
Homo sapiens; Mus musculus |
Experiment type |
Expression profiling by array Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
28864476 |
NIH grant(s) |
Grant ID |
Grant title |
Affiliation |
Name |
P01 CA168585 |
TARGETED COMBINATORIAL TREATMENT OF BRAF MELANOMAS |
UNIVERSITY OF CALIFORNIA LOS ANGELES |
ROGER S LO |
R01 CA176111 |
Overcoming acute, adaptive BRAF inhibitor resistance in melanoma |
UNIVERSITY OF CALIFORNIA LOS ANGELES |
ROGER S LO |
|
|
Submission date |
Nov 23, 2015 |
Last update date |
Dec 03, 2024 |
Contact name |
Willy Hugo |
E-mail(s) |
hwilly@mednet.ucla.edu
|
Organization name |
University of California, Los Angeles
|
Department |
Medicine
|
Street address |
10833 Le Conte Ave
|
City |
Los Angeles |
State/province |
California |
ZIP/Postal code |
90095 |
Country |
USA |
|
|
Platforms (4)
|
GPL6244 |
[HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version] |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
GPL21290 |
Illumina HiSeq 3000 (Homo sapiens) |
|
Samples (104)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE75299 |
Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment (RNA-seq) |
GSE75311 |
Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment (Affymetrix) |
GSE103630 |
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) |
GSE103658 |
Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment (RNA-seq_Patient.batch3) |
GSE103687 |
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] |
GSE103688 |
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] |
GSE103711 |
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] |
GSE103712 |
Expression changes in CD45neg subpopulation of YUMM1.7 melanoma pre MAPKi treatment vs. on MAPKi treatment [Y1.7.FPKM.batch3] |
GSE103713 |
Expression changes in YUMM1.7 melanoma with/without PD-L2 overexpression under BRAFi treatment in NSG mice [Y1.7.FPKM.batch4] |
GSE103725 |
Expression changes in Melanomas pre MAPKi treatment vs. on MAPKi treatment [Y1.7.FPKM.batch1.2] |
|
Relations |
BioProject |
PRJNA303171 |